Immucor | GenomeWeb

Immucor

The test can now be used to screen for sickle cell trait, a condition in which an individual carries one of the two abnormal genes responsible for sickle cell disease.


Immucor's PreciseType evaluates blood compatibility between donors and patients to help prevent mismatches that can cause potentially life-threatening reactions.

The two companies have had a years-long collaboration to develop and commercialize their NGS-based high-resolution HLA typing system.

NEW YORK (GenomeWeb) – Immucor last week announced its acquisition of Sentilus, an early stage company developing microarray-based applications for clinical use, including transfusion diagnostics.

NEW YORK (GenomeWeb) – Immucor today announced a collaboration with Stanford University spinout Sirona Genomics focused on human leukocyte antigen typing using next-generation sequencing.

NEW YORK (GenomeWeb) – Transfusion and transplantation diagnostics firm Immucor announced on Wednesday its acquisition of Sentilus for an undisclosed amount.

NEW YORK (GenomeWeb) – Grifols has garnered a CE-IVD mark for ID Core XT, a bead array-based assay for molecular blood group typing, the company said this week.

NEW YORK (GenomeWeb) — Immucor believes the recent US regulatory approval of its microarray-based PreciseType Human Erythrocyte Antigen test for determining blood compatibility will encourage more customers to introduce the assay in a clinical setting.

NEW YORK (GenomeWeb) – The US Food and Drug Administration on Wednesday approved the Immucor Precise Type Human Erythrocyte Antigen Molecular BeadChip Test for determining blood compatibility.

NEW YORK (GenomeWeb News) – Immucor announced after the close of the market Tuesday that a US Food and Drug Administration committee has recommended that its platform for human erythrocyte antigen typing be cleared for clinical use.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.